CNTB vs. CTMX

Last updated Jun 4, 2026

CNTB (Connect Biopharma Holdings Limited) and CTMX (CytomX Therapeutics, Inc.) are both stocks. Both operate in the Biotechnology industry within the Healthcare sector. At a 0.25 correlation, their price movements are largely independent.

Performance

CNTB vs. CTMX - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Connect Biopharma Holdings Limited (CNTB) and CytomX Therapeutics, Inc. (CTMX). The values are adjusted to include any dividend payments, if applicable.

Returns By Period

In the year-to-date period, CNTB achieves a -20.92% return, which is significantly higher than CTMX's -24.41% return.

CNTB

• 1D: 3.72%
• 1M: -10.08%
• YTD: -20.92%
• 6M: -15.85%
• 1Y: —
• 3Y*: —
• 5Y*: —
• 10Y*: —

CTMX

• 1D: 1.90%
• 1M: -22.97%
• YTD: -24.41%
• 6M: -19.50%
• 1Y: 21.51%
• 3Y*: 23.01%
• 5Y*: -13.81%
• 10Y*: -11.44%

*Multi-year figures are annualized to reflect compound growth (CAGR)

CNTB vs. CTMX - Yearly Performance Comparison

	2026 (YTD)	2025
CNTB Connect Biopharma Holdings Limited	-20.92%	41.71%
CTMX CytomX Therapeutics, Inc.	-24.41%	100.94%

Correlation

The correlation between CNTB and CTMX is 0.25, which is low. Their price movements are largely independent, making them effective diversification partners.

	Correlation
Correlation (All Time) Calculated using the full available price history since Sep 4, 2025	0.25

Fundamentals

Market Cap CNTB : $124.12M CTMX : $570.82M
EPS CNTB : -$1.28 CTMX : -$0.37
PS Ratio CNTB : 4.76 CTMX : 14.53
PB Ratio CNTB : 2.96 CTMX : 1.78
Total Revenue (TTM) CNTB : $26.03M CTMX : $35.54M
Gross Profit (TTM) CNTB : $25.37M CTMX : $24.77M
EBITDA (TTM) CNTB : -$72.75M CTMX : -$62.07M

Return for Risk

CNTB vs. CTMX — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

CTMX

CTMX Risk / Return Rank: 52
CTMX Sharpe Ratio Rank: 49
CTMX Sortino Ratio Rank: 56
CTMX Omega Ratio Rank: 55
CTMX Calmar Ratio Rank: 50
CTMX Martin Ratio Rank: 51

The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

CNTB vs. CTMX - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Connect Biopharma Holdings Limited (CNTB) and CytomX Therapeutics, Inc. (CTMX). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Risk / return metrics aren't available yet — we need at least 12 months of trading data to calculate them.

Sharpe Ratios by Period

	CNTB	CTMX	Difference
Sharpe Ratio (1Y) Calculated over the trailing 1-year period	—	0.22	—
Sharpe Ratio (5Y) Calculated over the trailing 5-year period	—	-0.10	—
Sharpe Ratio (10Y) Calculated over the trailing 10-year period	—	-0.10	—
Sharpe Ratio (All Time) Calculated using the full available price history	0.17	-0.11	+0.28

Drawdowns

CNTB vs. CTMX - Drawdown Comparison

The maximum CNTB drawdown since its inception was -41.73%, smaller than the maximum CTMX drawdown of -98.74%. Use the drawdown chart below to compare losses from any high point for CNTB and CTMX.

Drawdown Indicators

	CNTB	CTMX	Difference
Max Drawdown Largest peak-to-trough decline	-41.73%	-98.74%	+57.01%
Max Drawdown (1Y) Largest decline over 1 year	—	-53.19%	—
Max Drawdown (3Y) Largest decline over 3 years	—	-91.59%	—
Max Drawdown (5Y) Largest decline over 5 years	—	-94.16%	—
Max Drawdown (10Y) Largest decline over 10 years	—	-98.74%	—
Current Drawdown Current decline from peak	-39.57%	-90.59%	+51.02%
Average Drawdown Average peak-to-trough decline	-20.38%	-70.69%	+50.31%
Ulcer Index Depth and duration of drawdowns from previous peaks	—	23.71%	—

Volatility

Volatility by Period

	CNTB	CTMX	Difference
Volatility (1M) Calculated over the trailing 1-month period	—	13.80%	—
Volatility (6M) Calculated over the trailing 6-month period	—	68.42%	—
Volatility (1Y) Calculated over the trailing 1-year period	95.61%	96.69%	-1.08%
Volatility (5Y) Calculated over the trailing 5-year period, annualized	95.61%	141.79%	-46.18%
Volatility (10Y) Calculated over the trailing 10-year period, annualized	95.61%	111.36%	-15.75%

Dividends

CNTB vs. CTMX - Dividend Comparison

Neither CNTB nor CTMX has paid dividends to shareholders.

Tickers have no history of dividend payments

Financials

Frequently Asked Questions

Can I hold both CNTB and CTMX in my portfolio?

CNTB and CTMX have a correlation of 0.25, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.